世界の核医学イメージング装置市場(~2025年):製品別(SPECT(ハイブリッドSPECT、スタンドアロンSPECT)、ハイブリッドPET、平面シンチグラフィー)、用途別(腫瘍、心臓病、神経)、エンドユーザー別(病院、画像センター)

◆英語タイトル:Nuclear Imaging Equipment Market by Product (SPECT (Hybrid SPECT, Standalone SPECT), Hybrid PET, & Planar Scintigraphy), Application (Oncology, Cardiology & Neurology) & End user (Hospitals, Imaging Centers) - Global Forecasts to 2025
◆商品コード:MD1010
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2021年2月26日
◆ページ数:130
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥564,300見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥758,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥929,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

マーケッツアンドマーケッツ社は、世界の核医学イメージング装置市場規模が2020年38億ドルから2025年46億ドルまで、年平均3.9%成長すると予測しています。本調査レポートでは、核医学イメージング装置の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(単一光子放射型コンピュータ断層撮影(SPECT)イメージングシステム、ハイブリッドPETイメージングシステム、平面シンチグラフィイメージングシステム)分析、用途別(腫瘍、心臓病、神経)分析、エンドユーザー別(病院、画像センター、学術・研究センター、その他)分析、地域別分析、競争状況、企業情報などを掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・核医学イメージング装置の世界市場規模:製品別(単一光子放射型コンピュータ断層撮影(SPECT)イメージングシステム、ハイブリッドPETイメージングシステム、平面シンチグラフィイメージングシステム)
・核医学イメージング装置の世界市場規模:用途別(腫瘍、心臓病、神経)
・核医学イメージング装置の世界市場規模:エンドユーザー別(病院、画像センター、学術・研究センター、その他)
・核医学イメージング装置の世界市場規模:地域別
・競争状況
・企業情報
【レポートの概要】

“The nuclear imaging equipment market is expected to reach USD 4.6 billion by 2025 from USD 3.8 billion in 2020, at a CAGR of 3.9% during the forecast period.”
Growth in the market can primarily be attributed to factors such as shift from standalone to hybrid modalities, advances in radiotracers, the increasing focus on personalized medicine, investments through public-private partnerships to modernize diagnostic imaging centers, and the increasing incidence and prevalence of cancer and cardiac ailments.

“The SPECT imaging systems segment to hold the largest market share in 2020.”
Based on product, the nuclear imaging equipment market is segmented into hybrid PET imaging systems, SPECT imaging systems, and planar scintigraphy imaging systems. The SPECT imaging systems segment is further categorized into standalone and hybrid imaging systems. The SPECT imaging systems segment is expected to the largest share in 2019. The large share of this segment can be attributed to high adoption of SPECT imaing systems on account of lower cost as compared to hybrid PET imaging systems.

“The oncology segment to hold the largest market share in 2020.”
Based on application, the nuclear imaging equipment market is segmented into oncology, cardiology, neurology, and other applications. The oncology application segment is expected to register the highest CAGR during the forecast period. The major factors contributing to the growth of this segment include the rising incidence and prevalence of cancer across the globe, initiatives taken by public and private organizations to curb the rising cancer prevalence, and the development of advanced systems and radiotracers for oncology.

“The hospitals segment to hold the largest market share in 2020.”
Based on end user, the nuclear imaging equipment market is segmented into hospitals, imaging centers, academic & research centers, and other end users. Hospitals accounted for the largest share of the global nuclear imaging equipment market in 2019. This can be attributed to factors such as the need to improve the efficiency of diagnostic imaging procedures and the rising number of diagnostic imaging procedures performed in hospitals.

“The Asia Pacific region to witness the highest growth during the forecast period.”
Geographically, North America dominated the global nuclear imaging equipment market in 2020. However, the Asia Pacific market is expected to register the highest during the forecast period. The major factors driving the growth of the Asia Pacific market include increasing incidence of chronic diseases, rising awareness on the benefits of early disease diagnosis, and improvement of healthcare systems in the region.

Break of primary participants was as mentioned below:
 By Company Type: Tier I: 40%, Tier II: 30%, Tier III: 30%
 By Designation: C-Level Executives: 27%, Directors: 18%, Others: 55%
 By Region: North America: 40%, Europe: 20%, Asia Pacific : 30%, Latin America: 8%, Middle-East: 2%
Siemens Healthineers (Germany), GE Healthcare (US), and Philips Healthcare (Netherlands). were the leading players in the nuclear imaging equipment market.

Research Coverage
This report studies the nuclear imaging equipment market based on product, application, end-user, and region. The report also studies the different factors (such as drivers, restraints, challenges, and opportunities) affecting the market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the nuclear imaging equipment market, and their drivers, restraints, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the nuclear imaging equipment market and garner greater market shares.

【レポートの目次】

1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 21
1.2.2 MARKETS COVERED 22
FIGURE 1 NUCLEAR IMAGING EQUIPMENT MARKET SEGMENTATION 22
1.2.3 YEARS CONSIDERED FOR THE STUDY 22
1.3 CURRENCY 22
1.4 LIMITATIONS 23
1.5 STAKEHOLDERS 23
1.6 SUMMARY OF CHANGES 23
2 RESEARCH METHODOLOGY 24
2.1 RESEARCH DATA 24
2.2 RESEARCH METHODOLOGY STEPS 24
FIGURE 2 RESEARCH METHODOLOGY: NUCLEAR IMAGING EQUIPMENT MARKET 24
FIGURE 3 RESEARCH DESIGN 25
2.2.1 SECONDARY DATA 25
2.2.1.1 Key data from secondary sources 26
2.2.2 PRIMARY DATA 27
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 27
FIGURE 5 PRIMARY SOURCES 28
2.2.2.1 Key data from primary sources 28
2.3 MARKET SIZE ESTIMATION METHODOLOGY 29
FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 29
FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 30
2.4 MARKET DATA ESTIMATION AND TRIANGULATION 31
FIGURE 8 DATA TRIANGULATION METHODOLOGY 31
2.5 ASSUMPTIONS FOR THE STUDY 32
2.6 COVID-19-SPECIFIC ASSUMPTIONS 32
3 EXECUTIVE SUMMARY 33
FIGURE 9 NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT,
2020 VS. 2025 (USD MILLION) 33
FIGURE 10 NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION) 34
FIGURE 11 NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER,
2020 VS. 2025 (USD MILLION) 34
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE NUCLEAR IMAGING EQUIPMENT MARKET 35
4 PREMIUM INSIGHTS 36
4.1 NUCLEAR IMAGING EQUIPMENT OVERVIEW 36
FIGURE 13 GROWING POPULARITY OF HYBRID MODALITIES HAS DRIVEN THEIR ADOPTION 36
4.2 NORTH AMERICA: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT & COUNTRY (2019) 37
FIGURE 14 US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN NUCLEAR IMAGING EQUIPMENT IN 2019 37
4.3 NUCLEAR IMAGING EQUIPMENT MARKET SHARE, BY PRODUCT, 2020 VS. 2025 37
FIGURE 15 SPECT IMAGING SYSTEMS WILL CONTINUE TO DOMINATE THE MARKET IN 2025 37
4.4 NUCLEAR IMAGING EQUIPMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 38
FIGURE 16 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 38
5 MARKET OVERVIEW 39
5.1 INTRODUCTION 39
5.2 MARKET DYNAMICS 39
FIGURE 17 NUCLEAR IMAGING EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 39
5.2.1 DRIVERS 40
5.2.1.1 Rapidly growing geriatric population and the subsequent increase in the prevalence of associated diseases 40
TABLE 1 AGE-RELATED DISEASES AND ASSOCIATED DIAGNOSTIC MODALITIES 40
5.2.1.2 Shift from standalone to hybrid modalities 40
5.2.1.3 Increasing focus on personalized medicine 41
5.2.2 RESTRAINTS 41
5.2.2.1 High cost of diagnostic imaging systems 41
5.2.2.2 Declining reimbursements and increasing regulatory burden in
the US 41
5.2.3 OPPORTUNITIES 42
5.2.3.1 High growth opportunities in emerging countries 42
5.2.3.2 Growing demand for data integrated imaging systems 42
5.2.4 CHALLENGES 43
5.2.4.1 Hospital budget cuts 43
5.3 PRICING ANALYSIS 43
TABLE 2 REGIONAL PRICING ANALYSIS OF KEY NUCLEAR IMAGING MODALITIES 43
5.4 PORTER’S FIVE FORCES ANALYSIS 44
FIGURE 18 PORTER’S FIVE FORCES ANALYSIS 44
5.4.1 BARGAINING POWER OF BUYERS 44
5.4.2 BARGAINING POWER OF SUPPLIERS 45
5.4.3 THREAT OF NEW ENTRANTS 45
5.4.4 THREAT OF SUBSTITUTES 45
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 45
5.5 IMPACT OF COVID-19 ON THE NUCLEAR IMAGING EQUIPMENT MARKET 45
5.6 VALUE CHAIN ANALYSIS 46
FIGURE 19 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE 46
5.6.1 RESEARCH & DEVELOPMENT 46
5.6.2 MANUFACTURING & ASSEMBLY 46
5.6.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 46
5.7 SUPPLY CHAIN ANALYSIS 47
5.7.1 PROMINENT COMPANIES 47
5.7.2 SMALL & MEDIUM-SIZED ENTERPRISES 47
5.7.3 END USERS 47
FIGURE 20 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES 47
FIGURE 21 ECOSYSTEM ANALYSIS OF THE NUCLEAR IMAGING EQUIPMENT MARKET 48
6 NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT 49
6.1 INTRODUCTION 50
TABLE 3 NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 50
TABLE 4 NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT, 2018–2025 (UNITS) 50
6.2 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IMAGING SYSTEMS 51
TABLE 5 SPECT IMAGING SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION) 51
TABLE 6 SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION) 51
TABLE 7 SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2025 (UNITS) 51
TABLE 8 NORTH AMERICA: SPECT IMAGING SYSTEMS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 52
TABLE 9 EUROPE: SPECT IMAGING SYSTEMS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 52
TABLE 10 ASIA PACIFIC: SPECT IMAGING SYSTEMS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 52
6.2.1 HYBRID SPECT IMAGING SYSTEMS 53
6.2.1.1 Growing preference for dual-modality hybrid systems to drive market growth 53
TABLE 11 HYBRID SPECT IMAGING SYSTEMS MARKET, BY REGION,
2018–2025 (USD MILLION) 53
TABLE 12 NORTH AMERICA: HYBRID SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 53
TABLE 13 EUROPE: HYBRID SPECT IMAGING SYSTEMS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 54
TABLE 14 ASIA PACIFIC: HYBRID SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 54
6.2.2 STANDALONE SPECT IMAGING SYSTEMS 54
6.2.2.1 Low cost of standalone SPECT imaging systems is a key factor driving market growth 54
TABLE 15 STANDALONE SPECT IMAGING SYSTEMS MARKET, BY REGION,
2018–2025 (USD MILLION) 55
TABLE 16 NORTH AMERICA: STANDALONE SPECT IMAGING SYSTEMS MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 55
TABLE 17 EUROPE: STANDALONE SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 55
TABLE 18 ASIA PACIFIC: STANDALONE SPECT IMAGING SYSTEMS MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 56
6.3 HYBRID PET IMAGING SYSTEMS 56
6.3.1 HIGH COST OF HYBRID PET IMAGING SYSTEMS TO LIMIT MARKET GROWTH DURING THE FORECAST PERIOD 56
TABLE 19 HYBRID PET IMAGING SYSTEMS MARKET, BY REGION,
2018–2025 (USD MILLION) 57
TABLE 20 NORTH AMERICA: HYBRID PET IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 57
TABLE 21 EUROPE: HYBRID PET IMAGING SYSTEMS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 57
TABLE 22 ASIA PACIFIC: HYBRID PET IMAGING SYSTEMS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 58
6.4 PLANAR SCINTIGRAPHY IMAGING SYSTEMS 58
6.4.1 LOW SPECIFICITY OF PLANAR SCINTIGRAPHY IMAGING SYSTEMS TO LIMIT MARKET GROWTH 58
TABLE 23 PLANAR SCINTIGRAPHY IMAGING SYSTEMS MARKET, BY REGION,
2018–2025 (USD MILLION) 59
TABLE 24 NORTH AMERICA: PLANAR SCINTIGRAPHY IMAGING SYSTEMS MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 59
TABLE 25 EUROPE: PLANAR SCINTIGRAPHY IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 59
TABLE 26 ASIA PACIFIC: PLANAR SCINTIGRAPHY IMAGING SYSTEMS MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 60
7 NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION 61
7.1 INTRODUCTION 62
TABLE 27 NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 62
TABLE 28 SPECT IMAGING SYSTEMS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 62
TABLE 29 HYBRID PET IMAGING SYSTEMS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 62
TABLE 30 PLANAR SCINTIGRAPHY IMAGING SYSTEMS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 63
7.1.1 ONCOLOGY 63
7.1.1.1 Nuclear imaging systems can distinguish between benign and malignant tumors, which helps in precise diagnosis 63
TABLE 31 NUCLEAR IMAGING EQUIPMENT MARKET FOR ONCOLOGY, BY REGION, 2018–2025 (USD MILLION) 63
7.1.2 CARDIOLOGY 64
7.1.2.1 High prevalence of CVD is the major factor driving the growth of this segment 64
TABLE 32 NUCLEAR IMAGING EQUIPMENT MARKET FOR CARDIOLOGY, BY REGION, 2018–2025 (USD MILLION) 64
7.1.3 NEUROLOGY 64
7.1.3.1 Increasing demand for nuclear imaging in diagnosing neurological disorders is supporting the growth of this segment 64
TABLE 33 NUCLEAR IMAGING EQUIPMENT MARKET FOR NEUROLOGY, BY REGION, 2018–2025 (USD MILLION) 65
7.1.4 OTHER APPLICATIONS 65
TABLE 34 NUCLEAR IMAGING EQUIPMENT MARKET FOR OTHER APPLICATIONS,
BY REGION, 2018–2025 (USD MILLION) 66
8 NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER 67
8.1 INTRODUCTION 68
TABLE 35 NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER,
2018–2025 (USD MILLION) 68
8.2 HOSPITALS 68
8.2.1 RISING TREND OF MODERNIZING IMAGING WORKFLOW IS DRIVING
THE ADOPTION OF IMAGING SYSTEMS AMONG HOSPITALS 68
TABLE 36 NUCLEAR IMAGING EQUIPMENT MARKET FOR HOSPITALS, BY REGION, 2018–2025 (USD MILLION) 69
8.3 IMAGING CENTERS 69
8.3.1 GROWING NUMBER OF PRIVATE IMAGING CENTERS TO SUPPORT MARKET GROWTH 69
TABLE 37 NUCLEAR IMAGING EQUIPMENT MARKET FOR IMAGING CENTERS,
BY REGION, 2018–2025 (USD MILLION) 70
8.4 ACADEMIC & RESEARCH CENTERS 70
8.4.1 INCREASING COLLABORATIONS BETWEEN NUCLEAR IMAGING COMPANIES AND ACADEMIA TO PROPEL MARKET GROWTH 70
TABLE 38 NUCLEAR IMAGING EQUIPMENT MARKET FOR ACADEMIC & RESEARCH CENTERS, BY REGION, 2018–2025 (USD MILLION) 71
8.5 OTHER END USERS 71
TABLE 39 NUCLEAR IMAGING EQUIPMENT MARKET FOR OTHER END USERS,
BY REGION, 2018–2025 (USD MILLION) 71
9 NUCLEAR IMAGING EQUIPMENT MARKET, BY REGION 72
9.1 INTRODUCTION 73
TABLE 40 NUCLEAR IMAGING EQUIPMENT MARKET, BY REGION,
2018–2025 (USD MILLION) 73
9.2 NORTH AMERICA 73
TABLE 41 NORTH AMERICA: NUCLEAR IMAGING EQUIPMENT MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 73
TABLE 42 NORTH AMERICA: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 74
TABLE 43 NORTH AMERICA: SPECT IMAGING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 74
TABLE 44 NORTH AMERICA: NUCLEAR IMAGING EQUIPMENT MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 74
TABLE 45 NORTH AMERICA: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER, 2018–2025 (USD MILLION) 75
9.2.1 US 75
9.2.1.1 The US holds the largest share of the North American market 75
TABLE 46 US: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 76
TABLE 47 US: SPECT IMAGING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 76
TABLE 48 US: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 76
TABLE 49 US: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER,
2018–2025 (USD MILLION) 77
9.2.2 CANADA 77
9.2.2.1 A dearth of radiologists and long wait times for scans are the major challenges in the Canadian market 77
TABLE 50 CANADA: INDICATORS OF MARKET GROWTH 77
TABLE 51 CANADA: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 78
TABLE 52 CANADA: SPECT IMAGING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 78
TABLE 53 CANADA: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 78
TABLE 54 CANADA: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER,
2018–2025 (USD MILLION) 79
9.3 EUROPE 79
TABLE 55 EUROPE: NUCLEAR IMAGING EQUIPMENT MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 79
TABLE 56 EUROPE: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 79
TABLE 57 EUROPE: SPECT IMAGING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 80
TABLE 58 EUROPE: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 80
TABLE 59 EUROPE: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER,
2018–2025 (USD MILLION) 80
9.3.1 EU3 81
9.3.1.1 EU3 holds the largest share of the market in Europe 81
TABLE 60 GERMANY: INDICATORS OF MARKET GROWTH 81
TABLE 61 EU3: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 82
TABLE 62 EU3: SPECT IMAGING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 82
TABLE 63 EU3: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 83
TABLE 64 EU3: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER,
2018–2025 (USD MILLION) 83
9.3.2 RUSSIA 83
9.3.2.1 Initiatives to improve healthcare to boost the market growth 83
TABLE 65 RUSSIA: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 84
TABLE 66 RUSSIA: SPECT IMAGING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 84
TABLE 67 RUSSIA: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 84
TABLE 68 RUSSIA: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER,
2018–2025 (USD MILLION) 85
9.3.3 ROE 85
TABLE 69 ROE: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 85
TABLE 70 ROE: SPECT IMAGING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 86
TABLE 71 ROE: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 86
TABLE 72 ROE: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER,
2018–2025 (USD MILLION) 86
9.4 ASIA PACIFIC 87
FIGURE 22 APAC: NUCLEAR IMAGING EQUIPMENT MARKET SNAPSHOT 87
TABLE 73 ASIA PACIFIC: NUCLEAR IMAGING EQUIPMENT MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 88
TABLE 74 ASIA PACIFIC: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 88
TABLE 75 ASIA PACIFIC: SPECT IMAGING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 88
TABLE 76 ASIA PACIFIC: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 89
TABLE 77 ASIA PACIFIC: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER, 2018–2025 (USD MILLION) 89
9.4.1 JAPAN 89
9.4.1.1 Growing investments by key market players to drive market growth 89
TABLE 78 JAPAN: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 90
TABLE 79 JAPAN: SPECT IMAGING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 90
TABLE 80 JAPAN: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 91
TABLE 81 JAPAN: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER,
2018–2025 (USD MILLION) 91
9.4.2 CHINA 91
9.4.2.1 Increasing healthcare reforms and the rapidly growing aging population to drive market growth in China 91
TABLE 82 CHINA: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 92
TABLE 83 CHINA: SPECT IMAGING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 92
TABLE 84 CHINA: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 92
TABLE 85 CHINA: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER,
2018–2025 (USD MILLION) 93
9.4.3 INDIA 93
9.4.3.1 Uncertainties in healthcare policies to restrain market growth in India 93
TABLE 86 INDIA: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 94
TABLE 87 INDIA: SPECT IMAGING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 94
TABLE 88 INDIA: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 94
TABLE 89 INDIA: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER,
2018–2025 (USD MILLION) 95
9.4.4 REST OF ASIA PACIFIC 95
TABLE 90 ROAPAC: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 96
TABLE 91 ROAPAC: SPECT IMAGING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 96
TABLE 92 ROAPAC: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 96
TABLE 93 ROAPAC: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER,
2018–2025 (USD MILLION) 97
9.5 REST OF THE WORLD 97
TABLE 94 ROW: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 98
TABLE 95 ROW: SPECT IMAGING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 98
TABLE 96 ROW: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 98
TABLE 97 ROW: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER,
2018–2025 (USD MILLION) 99
10 COMPETITIVE LANDSCAPE 100
10.1 OVERVIEW 100
FIGURE 23 KEY DEVELOPMENTS IN THE NUCLEAR IMAGING EQUIPMENT MARKET 100
10.2 MARKET SHARE ANALYSIS 101
FIGURE 24 NUCLEAR IMAGING EQUIPMENT MARKET SHARE ANALYSIS (2019) 101
10.3 COMPETITIVE LEADERSHIP MAPPING 102
10.3.1 STARS 102
10.3.2 EMERGING LEADERS 102
10.3.3 PERVASIVE 102
10.3.4 EMERGING COMPANIES 102
FIGURE 25 NUCLEAR IMAGING EQUIPMENT MARKET: COMPETITIVE LEADERSHIP MAPPING (2019) 103
10.4 COMPETITIVE SCENARIO 104
10.4.1 PRODUCT LAUNCHES 104
TABLE 98 PRODUCT LAUNCHES (2017–2020) 104
10.4.2 ACQUISITIONS 104
TABLE 99 ACQUISITIONS (2017–2020) 104
10.4.3 AGREEMENTS, PARTNERSHIPS, & COLLABORATIONS 104
TABLE 100 AGREEMENTS, PARTNERSHIPS, & COLLABORATIONS (2017–2020) 104
11 COMPANY PROFILES 105
(Business overview, Products offered, Recent developments)*
11.1 SIEMENS HEALTHINEERS 105
FIGURE 26 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2019) 105
11.2 GE HEALTHCARE 108
FIGURE 27 GE HEALTHCARE: COMPANY SNAPSHOT (2019) 108
11.3 KONINKLIJKE PHILIPS N.V. 111
FIGURE 28 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2019) 111
11.4 DIGIRAD CORPORATION 114
11.5 NEUSOFT MEDICAL SYSTEMS CO., LTD. 115
11.6 CANON INC. 116
FIGURE 29 CANON INC.: COMPANY SNAPSHOT (2019) 116
11.7 SURGICEYE GMBH 118
11.8 DDD-DIAGNOSTIC A/S 119
11.9 CMR NAVISCAN CORPORATION 120
11.10 MEDISO LTD. 121
11.11 SHIMADZU CORPORATION 122
FIGURE 30 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2019) 122
11.12 PERKINELMER, INC. 124
FIGURE 31 PERKINELMER, INC.: COMPANY SNAPSHOT (2018) 124
11.13 MILABS B.V. 126
11.14 MR SOLUTIONS LTD. 127
*Business overview, Products offered, Recent developments might not be captured in case of unlisted companies.
12 APPENDIX 128
12.1 DISCUSSION GUIDE 128
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 131
12.3 AVAILABLE CUSTOMIZATIONS 133
12.4 RELATED REPORTS 133
12.5 AUTHOR DETAILS 134



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の核医学イメージング装置市場(~2025年):製品別(SPECT(ハイブリッドSPECT、スタンドアロンSPECT)、ハイブリッドPET、平面シンチグラフィー)、用途別(腫瘍、心臓病、神経)、エンドユーザー別(病院、画像センター)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆